MedTrace Logo

The Use of Musculoskeletal Ultrasound for the Detection of ICU-Acquired Weakness

NCT05048953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2023-12-22

No results posted yet for this study

Summary

Intensive Care Unit-Acquired Weakness (ICU-AW) is a clinical entity frequently encountered in critically ill patients that have both short term and long-term implications.

The current gold standard of diagnosis is by assessment of manual muscle strength, using the 6-grade Medical Research Council (MRC) sum score. However, not all Intensive Care Unit (ICU) admitted patients are conscious or cooperative enough to use MRC sum score for the diagnosis of ICU-AW. Ultrasound imaging of muscles has emerged as a valid and reliable tool for providing qualitative and quantitative details about muscle disease and has been suggested as an alternative to assess ICU-AW in critically ill patients in whom the MRC cannot be assessed. This study will be a prospective observational study to evaluate the relationship between the trend of changes in muscle thickness, echogenicity and fasciculations during the first 7 days of ICU stay as measured by ultrasound and ICU-AW among critically ill patients. The study will be performed in the ICU of TU Teaching Hospital, Kathmandu, Nepal for 1 year. All newly admitted adult patients ≥ 16 years of age, expected to stay in ICU / critical care areas for at least 7 days, barring the exclusion criteria, will be included in the study and evaluated for MRC sum score and skeletal muscle thickness, echogenicity and fasciculations using ultrasound on day 1, day 4 and day 7. The measurements will then be statistically analyzed to see if there is any relationship between trend of changes in muscle thickness, echogenicity and fasciculations and ICU-AW

Conditions

  • ICU Acquired Weakness

Interventions

DIAGNOSTIC_TEST

Muscle ultrasound measurements (the index test)

The following parameters will be measured by muscle ultrasound 1. Muscle thickness 2. Muscle echogenicity 3. Muscle fasciculations

Sponsors & Collaborators

  • Tribhuvan University Teaching Hospital, Institute Of Medicine.

    collaborator OTHER

  • B.P. Koirala Institute of Health Sciences

    lead OTHER

Principal Investigators

  • MOHAN SHARMA, MBBS, MD, Mch · IOM, TUTH, MMC

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-11-01
Completion
2022-11-01

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05048953 on ClinicalTrials.gov